Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans

British Journal of Cancer

Volumn 67, Issue 2, 1993, Pages 358-361

  Bergenheim, A T ^a   Gunnarsson, P O ^b   Edman, K ^b   Von Schoultz, E ^a   Hariz, M I ^a   Henriksson, R ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Kabi Pharmacia   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG BINDING PROTEIN; DRUG METABOLITE; ESTRAMUSTINE; ESTRAMUSTINE PHOSPHATE;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER TISSUE; CLINICAL ARTICLE; CYST FLUID; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG RETENTION; DRUG UPTAKE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CARRIER PROTEINS; EPENDYMOMA; ESTRAMUSTINE; ESTRONE; FEMALE; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; NITROGEN MUSTARD COMPOUNDS; SUPPORT, NON-U.S. GOV'T;

EID: 0027417973     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.65     Document Type: Article

References (25)

1. ANDERSSON, S.-B., GUNNARSSON, P.O., NILSSON, T. & PLYMFORS-CHELL, G. (1981). Metabolism of estramustine phosphate in patients with prostatic carcinoma. Eur. J. Drug. Metab. Pharma-cokinet., 6, 149-154.
2. ANDERSSON, S.-B., LUNDGREN, R. & SVENSSON, L. (1982). Gas chromatographic determination of four metabolites of estramustine phosphate in plasma. Acta Pharmacol. Swe., 19, 1-10.
3. BERGH, J., BJÖRK, P., WESTLIN, J E., BRODIN, O. & NILSSON, S. (1988). Expression of estramustine-binding protein (EMBP) in human lung cancer cell lines. Cancer Res., 48, 4615-4619.
4. BJÖRK, P., FRITJOFSSON, Å., HARTLEY-ASP, B. (1985). Uptake and binding of estramustine and estromustine, metabolites of estramustine phosphate (Estracyt), in the human prostate, and new aspects on the cytotoxic activity of estramustine phosphate in vitro. In Experimentelle Urologie, Harzmann, R. (ed) pp. 341-353. Springer Verlag: Berlin-Heidelberg.
5. CACERES, A., BINDER, L.I., PAYNE, M R., BENDER, P., REBHUN, L. & STEWARD, O. (1984). Differential subcellular localization of tubulin and the microtubule-associated protein MAP-2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodies. J. Neuro sci., 4, 394-410.
6. FLÜCHTER, S.H., NELDE, H J., BJÖRK, P., MÜNTZING, J. & BICH-LER, K.-H. (1989). Effects of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study. The Prostate, 14, 27-43.
7. FORSGREN, B., BJÖRK, P., CARLSTRÖM, K., GUSTAFSSON, J. -Å., POUSETTE, Å. & HÖGBERG, B. (1979a). Purification and distribution of a major protein in rat prostrate that binds to estramustine, a nitrogen mustard derivate of estradiol-170. Proc. Nat. Acad. Sci., 76, 3149-3153.
8. FORSGREN, B., GUSTAFSSON, J.-Å., POUSETTE, Å. & HÖGBERG, B. (1979b). Binding characteristics of a major protein in rat prostate cytosol that interacts with estramustine, a nitrogen mustard derivate of 17 ß-estradiol. Cancer Res., 39, 5155-5164.
9. FRIDÉN, B., WALLIN, M., DEINUM, J., PRASADE, V. & LUDUENA, R. (1987). Effect of estramustine-phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP-2 or the tubulin fragment of MAP-2. Arch. Biochem. Biophys., 257, 123-130.
10. GUNNARSSON, P.O., ANDERSSON, S.-B., JOHANSSON, S. Å., NILSSON, T. & PLYM-FORSHELL, G. (1984). Pharmacokinetics of estramustine phosphate in prostatic cancer patients. Eur. J. Clin. Pharmacol., 26, 113-119.
11. GUNNARSSON, P.O., DAVIDSSON, T., ANDERSSON, S.-B., BACK-MAN, C. & JOHANSSON, S.-Å. (1990). Impairment of estramustine phosphate absorption by concurrent milk and food intake. Eur. J. Clin. Pharma-col., 38, 189-193.
12. HARTLEY-ASP, B. (1984). Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3. The Prostate, 5, 93-100.
13. VON HOLST, H., KNOCHENHAUER, E., BLOMGREN, H., COLLINS, V.P., EHN, L., LINDQUIST, M., NOREN, G. & PETERSON, C. (1990). Uptake of adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas. Acta Neurochir. (Wien), 104, 13-16.
14. HSU, S.M., RAINE, L. & FANGER, H. (1981). Use of Avidin-Biotin-Peroxidase complex (ABC) in immunoperoxidase tech-niques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem, Cytochem., 29, 577-580.
15. KRUSE, E. & HARTLEY-ASP, B. (1988a). Uptake and metabolism of estramustine in the Dunning R3327H tumour. In Vivo, 2, 371-376.
16. KRUSE, E., JOHANSSON, S.-Å., HARTLEY-ASP, B. & GUNNARSSON, P.O. (1988b). Distribution and metabolism of estramustine in HeLa cells and the human prostatic tumour cell line 1013L. Biochem. Pharmacol., 37, 3161-3167.
17. NORLÉN, B.J., ANDERSSON, S.-B., BJÖRK, P., GUNNARSSON, P.O. & FRITJOFSSON, Å. (1988). Uptake of estramustine phosphate (Estracyt) metabolites in prostatic cancer. J. Urology, 140, 1058-1062.
18. VON SCHOULTZ, E., LUNDBLAD, D., BERGH, J., GRANKVIST, K. & HENRIKSSON, R. (1988). Estramustine binding protein and antiproliferative effect of estramustine in human glioma cell lines. Br. J. Cancer, 58, 326-329.
19. VON SCHOULTZ, E., GUNNARSSON, P.O. & HENRIKSSON, R. (1989). Uptake, metabolism and antiproliferative effect of estramustine phosphate in human glioma cell lines. Anticancer Res., 9, 1713-1716.
20. VON SCHOULTZ, E., LUNDGREN, E. & HENRIKSSON, R. (1990). Effects of estramustine and its constituents on human malignant glioma cells. Anticancer Res., 10, 693-696.
21. VON SCHOULTZ, E., BERGENHEIM, T., GRANKVIST, K.P. & HENRIKSSON, R. (1991). Estramustine binding protein in human brain tumour tissue. J. Neurosurg., 74, 962-964.
22. STEARNS, M. & TEW, K.D. (1988). Estramustine binds MAP-2 to inhibit microtubule assembly in vitro. Cell Sci., 89, 331-342.
23. STERNBERGER, L.A. (1979). The unlabelled antibody peroxidaseantiperoxidase (PAP) method. In Immunochemistry, 2nd edition, p 104, John Wiley & Sons: New York.
24. VALLEE, R.B. (1982). A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins. J. Cell Biol., 92, 435-442.
25. WHITTLE, I.R., MACPHERSON, J.S., MILLER, J.D. & SMYTH, J.F. (1990). The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications. J. Neurosurg., 72, 721-725.